TOZRILBI Trademark

Trademark Overview

On Monday, May 18, 2026, a trademark application was filed for TOZRILBI with the United States Patent and Trademark Office. The USPTO has given the TOZRILBI trademark a serial number of 99830101. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, July 7, 2026. This trademark is owned by AstraZeneca AB. The TOZRILBI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, dermatological, neurological, gastrointestinal, and immune systems; Antibodies for medical purposes; Pharmaceutical preparations for the treatment of infection, inflammation, hematological, and autoimmune related diseases and disorders; Vaccines
tozrilbi

General Information

Serial Number99830101
Word MarkTOZRILBI
Filing DateMonday, May 18, 2026
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, July 7, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 28, 2026

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, dermatological, neurological, gastrointestinal, and immune systems; Antibodies for medical purposes; Pharmaceutical preparations for the treatment of infection, inflammation, hematological, and autoimmune related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 18, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type64 - NOT AVAILABLE
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Monday, May 18, 2026NEW APPLICATION ENTERED
Monday, May 18, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 18, 2026APPLICATION FILING RECEIPT MAILED
Friday, June 26, 2026ASSIGNED TO EXAMINER
Friday, June 26, 2026APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

tozrilbi pharmaceutical preparations disorders diseases treatment purposes antibodies medical infection autoimmune